Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Zovegalisib | 2733573-94-7 | C29H14ClF5N6O2 | 1 ML
Supplier: Medchemexpress LLC HY15330610MM/1ML
Zovegalisib (RLY-2608) is an orally active, first-in-class, allosteric, mutant-selective inhibitor of PI3Kα with anti-tumor activity. It inhibits tumor growth in PIK3CA-mutant xenograft mouse models with minimal impact on insulin levels. This compound is for research use only and not sold to patients.
- First-in-class, allosteric, mutant-selective inhibitor of PI3Kα
- Exhibits anti-tumor activity
- Inhibits tumor growth in PIK3CA-mutant xenograft mice models
- Minimal impact on insulin levels
- High purity (98.80%)
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?